13 January 2020 | GENEVA - Significant improvements to the diagnosis of tuberculosis (TB) and rifampicin resistance in adults and children are expected, following key updates on new molecular assays, announced by the World Health Organization (WHO) in a Rapid Communication released today.

The World Health Organization (WHO) Global TB Program released a newsletter highlighting the overall progress in the global TB response in 2019. The Global TB Report 2019 is now available in app form.

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

29 November 2019 | Hanoi: The pace of progress in addressing TB in children and adolescents remains slow, especially in ensuring access to TB prevention and care. To address this critical issue, WHO convened a global consultation on 26-28 November in Hanoi, Viet Nam, bringing together over 100 stakeholders from across 12 countries including national TB programmes, paediatric societies, technical and financial partners as well as civil society. The consultation was hosted by the Viet Nam Government.

To mark the 2nd anniversary of the first-ever WHO Global Ministerial Conference on Ending TB in Moscow, the World Health Organization (WHO) Global TB Program released an overview of the key progress achieved so far regarding the implementation of the commitments made in the Moscow Declaration and the UN High-Level Meeting on TB.

The World Health Organization (WHO) and the International Union Against Tuberculosis and Lung Disease (The Union) released statements recognizing World Diabetes Day (November 14) and pressing for a more coordinated global approach to tackling the urgent co-epidemic of TB and diabetes.

The Guideline Development Group convened a meeting on 12-14 November 2019 on update of the World Health Organization (WHO) drug-resistant TB treatment guidelines.

The World Health Organization (WHO)'s Global TB Program released a newsletter presenting the WHO events around the 50th Union World Conference on Lung Health.

The World Health Organization now recommends more broader use of urinary LAM assays for diagnosis of TB in people living with HIV.

30 October 2019 | Geneva - The World Health Organization (WHO) has updated its guidance for the use of lateral flow urine lipoarabinomannan assay (LAM) in the diagnosis of tuberculosis (TB). Following new evidence, WHO now recommends a broader use of urinary LAM assays for diagnosis of TB in people living with HIV.